Analysis of the Involvement of Different Ceramide Variants in the Response to Hydroxyurea Stress in Baker's Yeast
Open Access
- 19 January 2016
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 11 (1) , e0146839
Abstract
Sphingolipids have been identified as important signaling compounds in stress responses. However, it is not always clear how different sphingolipid profiles are achieved in a particular stress situation. Here we propose a detailed mass action model, containing 42 dependent variables and 137 reactions, that offers explanations of the roles of variant ceramides species, which differ in the lengths of their fatty acyl chains and their saturation state, in the response to hydroxyurea stress. The simulations demonstrate that the cells manage to achieve hydroxyurea tolerance through a well-coordinated, differential usage of the variant ceramide species. Moreover, the results suggest that key enzymes have different affinities toward saturated and unsaturated fatty acyl chains, which implies that the saturation state affords the cells with an additional mode of regulation that had not been recognized so far. These conclusions from our computational analysis are yet to be validated experimentally.Keywords
This publication has 20 references indexed in Scilit:
- Coordination of Rapid Sphingolipid Responses to Heat Stress in YeastPLOS Computational Biology, 2013
- Sphingolipid Signaling in Metabolic DisordersCell Metabolism, 2012
- Canonical Modeling of the Multi-Scale Regulation of the Heat Stress Response in YeastMetabolites, 2012
- Mathematical Modeling and Validation of the Ergosterol Pathway in Saccharomyces cerevisiaePLOS ONE, 2011
- Hydroxyurea Sensitivity Reveals a Role for ISC1 in the Regulation of G2/MJournal of Biological Chemistry, 2009
- Coordination of the dynamics of yeast sphingolipid metabolism during the diauxic shiftTheoretical Biology and Medical Modelling, 2007
- Simulation and validation of modelled sphingolipid metabolism in Saccharomyces cerevisiaeNature, 2005
- Hydroxyurea in the Treatment of HIV InfectionDrug Safety, 2003
- Stories about acyl chainsBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2000
- Hydroxyurea for the Treatment of Sickle Cell DiseaseActa Haematologica, 1992